DK0958281T3 - Opspaltning af ritalinsyresalt - Google Patents

Opspaltning af ritalinsyresalt

Info

Publication number
DK0958281T3
DK0958281T3 DK98900603T DK98900603T DK0958281T3 DK 0958281 T3 DK0958281 T3 DK 0958281T3 DK 98900603 T DK98900603 T DK 98900603T DK 98900603 T DK98900603 T DK 98900603T DK 0958281 T3 DK0958281 T3 DK 0958281T3
Authority
DK
Denmark
Prior art keywords
cleavage
acid salt
salt
acid
ritalic acid
Prior art date
Application number
DK98900603T
Other languages
English (en)
Inventor
Hooshang Shahriari Chi Zavareh
Gerard Andrew De Montfo Potter
Original Assignee
Celltech Pharma Europ Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celltech Pharma Europ Ltd filed Critical Celltech Pharma Europ Ltd
Application granted granted Critical
Publication of DK0958281T3 publication Critical patent/DK0958281T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Investigating Or Analyzing Materials By The Use Of Ultrasonic Waves (AREA)
  • Gyroscopes (AREA)
DK98900603T 1997-01-17 1998-01-14 Opspaltning af ritalinsyresalt DK0958281T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9700912.0A GB9700912D0 (en) 1997-01-17 1997-01-17 Resolution

Publications (1)

Publication Number Publication Date
DK0958281T3 true DK0958281T3 (da) 2004-06-14

Family

ID=10806137

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98900603T DK0958281T3 (da) 1997-01-17 1998-01-14 Opspaltning af ritalinsyresalt

Country Status (17)

Country Link
US (1) US6441178B2 (da)
EP (1) EP0958281B1 (da)
JP (1) JP2001508791A (da)
AT (1) ATE262510T1 (da)
AU (1) AU5569198A (da)
CA (1) CA2272716C (da)
CZ (1) CZ293045B6 (da)
DE (1) DE69822606T2 (da)
DK (1) DK0958281T3 (da)
ES (1) ES2218799T3 (da)
GB (1) GB9700912D0 (da)
HU (1) HUP0000777A3 (da)
NO (1) NO993517L (da)
PL (1) PL189745B1 (da)
PT (1) PT958281E (da)
WO (1) WO1998031668A1 (da)
ZA (1) ZA98374B (da)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5837284A (en) 1995-12-04 1998-11-17 Mehta; Atul M. Delivery of multiple doses of medications
US5922736A (en) * 1995-12-04 1999-07-13 Celegene Corporation Chronic, bolus administration of D-threo methylphenidate
US6486177B2 (en) * 1995-12-04 2002-11-26 Celgene Corporation Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
US6962997B1 (en) 1997-05-22 2005-11-08 Celgene Corporation Process and intermediates for resolving piperidyl acetamide steroisomers
US7247730B2 (en) * 2003-03-07 2007-07-24 Isp Investments Inc. Process for the preparation of dexmethylphenidate hydrochloride
US20050239830A1 (en) * 2004-04-26 2005-10-27 Vikram Khetani Methods of diminishing co-abuse potential
CN101076248A (zh) * 2004-12-09 2007-11-21 塞尔基因公司 使用d-苏型哌甲酯的治疗
US8552030B2 (en) * 2009-05-07 2013-10-08 Malladi Drugs & Pharmaceuticals Ltd. Process for the preparation of d-threo-ritalinic acid hydrochloride by resolution of dl-threo-ritalinic acid using chiral carboxylic acid
EP2937336A1 (en) * 2010-12-17 2015-10-28 Rhodes Technologies Low-temperature synthesis of methylphenidate hydrochloride
US9119809B2 (en) 2011-03-23 2015-09-01 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US8927010B2 (en) 2011-03-23 2015-01-06 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
WO2012129551A1 (en) 2011-03-23 2012-09-27 Ironshore Pharmaceuticals & Development, Inc. Methods and compositions for treatment of attention deficit disorder
US9498447B2 (en) 2011-03-23 2016-11-22 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US9283214B2 (en) 2011-03-23 2016-03-15 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10905652B2 (en) 2011-03-23 2021-02-02 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US11241391B2 (en) 2011-03-23 2022-02-08 Ironshore Pharmaceuticals & Development, Inc. Compositions for treatment of attention deficit hyperactivity disorder
US10292937B2 (en) 2011-03-23 2019-05-21 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US9603809B2 (en) 2011-03-23 2017-03-28 Ironshore Pharmaceuticals & Development, Inc. Methods of treatment of attention deficit hyperactivity disorder
US8916588B2 (en) 2011-03-23 2014-12-23 Ironshore Pharmaceuticals & Development, Inc. Methods for treatment of attention deficit hyperactivity disorder
WO2014083572A1 (en) * 2012-11-29 2014-06-05 Zcl Chemicals Limited A process for the preparation of d-threo-ritalinic acid salts via novel salts of intermediate thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2957880A (en) * 1953-12-23 1960-10-25 Ciba Pharm Prod Inc Process for the conversion of stereoisomers
SU466229A1 (ru) * 1973-01-23 1975-04-05 Всесоюзный научно-исследовательский химико-фармацевтический институт им. С.Орджоникидзе Способ получени гидрохлорида метилового эфира трео- -фенил- (пиперидил-2)-уксусной кислоты
US4285964A (en) 1979-08-30 1981-08-25 Continental Pharma Salts of (+)-catechine, their preparation and use, and compositions containing these salts
US5162344A (en) 1987-05-04 1992-11-10 Robert Koch Procaine double salt complexes
JP2000504008A (ja) * 1996-02-02 2000-04-04 メデバ・ユアラプ・リミテッド D―トレオ―(r,r)―メチルフェニデートの調製およびエピメリゼーションによる不要エナンチオマーリサイクルの方法
CA2243542C (en) * 1996-03-08 2003-02-18 Medeva Europe Limited Resolution of threo-methylphenidate

Also Published As

Publication number Publication date
CZ230299A3 (cs) 1999-11-17
ZA98374B (en) 1999-01-22
NO993517D0 (no) 1999-07-16
AU5569198A (en) 1998-08-07
WO1998031668A1 (en) 1998-07-23
PL189745B1 (pl) 2005-09-30
DE69822606T2 (de) 2004-08-05
CZ293045B6 (cs) 2004-01-14
EP0958281A1 (en) 1999-11-24
ES2218799T3 (es) 2004-11-16
EP0958281B1 (en) 2004-03-24
JP2001508791A (ja) 2001-07-03
GB9700912D0 (en) 1997-03-05
HUP0000777A3 (en) 2000-10-30
CA2272716C (en) 2007-09-18
US6441178B2 (en) 2002-08-27
ATE262510T1 (de) 2004-04-15
US20020019535A1 (en) 2002-02-14
PL334838A1 (en) 2000-03-27
NO993517L (no) 1999-07-16
DE69822606D1 (de) 2004-04-29
HUP0000777A2 (hu) 2000-09-28
PT958281E (pt) 2004-07-30
CA2272716A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
DK0958281T3 (da) Opspaltning af ritalinsyresalt
DE3883495D1 (de) Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung.
DE69924467D1 (de) Verfahren zur herstellung von donepezilderivaten
CY1110919T1 (el) Μεθοδος για τον ενζυματικο διαχωρισμο εναντιομερων της 3(r)- kai 3(s)-υδροξυ-1-μεθυλο-4-(2,4,6-τριμεθοξυφαινυλο)-1,2,3,6-τετραϋδρο-πυριδινης ή των εστερων καρβοξυλικου οξεος αυτης.
DK0885191T3 (da) Opspaltning af threo-methylphenidat
DK0402752T3 (da) N-Heteroaryl-purin-6-aminer, fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ATE303377T1 (de) Verfahren zur racemizierung
DE60015563D1 (de) Verfahren zur herstellung von benzoperhydroisoindolen
CO4940417A1 (es) DERIVADOS DE 2,3-DIHIDROFURO[3,2-b]PIRIDINA, SU PREPARACION Y SU APLICACION EN TERAPEUTICA
ATE240286T1 (de) Verfahren zur herstellung von 1-aryl-3- cyclopropyl-1,3-propandionen
PT1156999E (pt) Metodo para a preparacao de um beta-aminoester quiral
EP0997534A3 (de) Verfahren zur Racematspaltung von Arylalkylcarbonsäureestern
DK1140794T3 (da) Hidtil ukendt fremgangsmåde til fremstilling af chirale aminosyrer
DK288489D0 (da) Fremgangsmaade til fremstilling af 4-chlor-3-alkoxy-but-2e-en-syrealkylestere
DE602004006021D1 (de) Verfahren zur racematspaltung von nefopam
ATE375355T1 (de) Verfahren zur herstellung von cefpodoxim-proxetil
ATE216989T1 (de) Trennung von octahydroisochinoline enantiomeren
ES2031921T3 (es) Derivados 5-aminoetilados de la oxazolidinona-2, su procedimiento de fabricacion y su aplicacion terapeutica.
SE9901712D0 (sv) New process
DK1196415T3 (da) Fremgangsmåde til fremstilling af lysergsyre
KR890701679A (ko) 특정수지용 난연제로서의 테트라할로프탈레이트 에스테르
DE3864286D1 (de) Herstellungsverfahren von trifluormethylverbindungen.
ATE360615T1 (de) Enantiomerentrennung von mefloquin mit o,o-di-p- aroylweinsäure